26 February 2026
Linerixibat accepted for priority review in China for cholestatic pruritus in patients with primary biliary cholangitis GSK plc (LSE/NYSE: GSK) today announced that its…
Bepirovirsen accepted for regulatory review in Japan as a potential first-in-class treatment for chronic hepatitis B GSK plc (LSE/NYSE: GSK) today announced that Japan’s…
25 February 2026
Today, ASML Holding NV (ASML) has published its 2025 Annual Reports. The 2025 Annual Reports ‘Powering technology forward with you’, highlight ASML’s commitment to…
Jet2 plc (“the Group” or “the Company”) Trading Update FY26 profit in line with expectations and operationally well-set ahead of Gatwick launch Jet2, the…
Interim results Six months ended 31 December 2025 25 February 2026 Reported results Adjusted results(1) F26 H1 vs F25 H1…
24 February 2026
B.P. Marsh & Partners Plc (“B.P. Marsh”, the “Company” or the “Group”) “Continued strong performance delivering increased returns to shareholders“ Trading Update Year Ended…
20 February 2026
SEGRO plc’s Full Year 2025 Results have been submitted in full unedited text to the Financial Conduct Authority’s National Storage Mechanism and will be…
19 February 2026
In 2025, Euronext delivered another year of double-digit growth, driven by the expansion of non-volume-related businesses, resilient trading, clearing revenues and cost discipline. Euronext…